Core Viewpoint - The Chinese medical equipment industry is experiencing significant growth and innovation, marking a shift towards self-sufficiency and high-end manufacturing, which is transforming both domestic and global healthcare landscapes [1][2][3]. Industry Growth - During the 14th Five-Year Plan period, the medical equipment industry in China has achieved a compound annual growth rate of approximately 10.7%, with the market size expected to reach 1.35 trillion yuan by 2024, maintaining its position as the second-largest market globally [2]. - By the end of 2024, the number of medical device manufacturing companies in China is projected to exceed 33,000, representing a 27.8% increase compared to the end of the 13th Five-Year Plan [2]. Technological Advancements - The industry is advancing towards high-end and intelligent medical equipment, with innovations such as zero-magnetic medical imaging devices and integrated radiation therapy technologies being introduced [3]. - Since the beginning of the 14th Five-Year Plan, 315 innovative medical devices have been approved, with 272 of these being domestic products, accounting for 86.3% [3]. - Key technologies such as carbon ion therapy systems and artificial hearts have achieved domestic production, reversing the previous scenario where imported devices dominated the high-end market [3]. Clinical Applications - The integration of artificial intelligence and advanced imaging technologies is enhancing the capabilities of medical equipment, with over 1.045 million patent applications filed in the medical equipment sector during the 14th Five-Year Plan [4]. - Innovations like the full-body PET/CT scanner have significantly reduced scanning times and improved imaging capabilities, demonstrating the effectiveness of domestic innovations in clinical settings [4]. Policy Support and Infrastructure - The Chinese government has implemented multiple policies to promote high-quality development in the medical equipment sector, including key projects and planning documents aimed at enhancing research, industry, and application [6]. - Continuous improvements in grassroots medical facilities are being made, with significant upgrades in medical equipment conditions and accelerated construction of county-level medical communities [6]. Accessibility and Affordability - The emergence of domestic surgical robots has led to a noticeable decrease in equipment prices, enabling more county-level hospitals to perform robotic surgeries [8]. - Advanced technologies such as AI-assisted diagnostics and remote surgery systems are breaking geographical barriers, allowing patients in rural areas to access quality medical services [8]. Conclusion - The ultimate goal of the development of medical equipment is to benefit public health, with ongoing efforts to ensure that more patients can access and afford high-quality domestic medical equipment [9].

"下一步，国家药监局将持续跟踪医疗器械创新发展的新情况新进展，不断总结新经验、探索新规律、 推出新举措，批准更多更好地创新高端医疗器械上市，为推动我国由'制械大国'向'制械强国'的历史性 跨越不断贡献力量，更好满足公众健康需求。"7月5日，国家药品监督管理局副局长徐景和在国新办举 行的第18场"权威部门话开局"系列主题发布会上如是说。 近年来，党中央、国务院对医疗器械产业创新发展高度重视，多次强调要加快补齐我国高端医疗装备短 板，加快关键核心技术攻关，突破技术装备瓶颈，实现高端医疗装备自主可控。 据徐景和介绍，为推动我国医疗器械产业创新高质量发展，国家药监局主要做了以下几个方面的工作： 一是强化顶层设计，推进部门协同。如印发《"十四五"国家药品安全及促进高质量发展规划》，《"十 四五"医疗装备产业发展规划》等文件，形成政策合力。再比如，牵头建立人工智能医疗器械、医用生 物材料两个技术创新合作平台，加快相关科技成果在医疗器械领域的转化应用，配合开展相关产品揭榜 挂帅等工作，聚焦科技发展前沿，提前布局。 二是加强监管科学研究，不断创新审查举措。建立技术审评向产品研发阶段前移的工作机制，重点围绕 如ECMO、粒子治 ...

华夏时报记者郭怡琳于娜北京报道 近日，一则"ECMO跨省转运800公里收费2.8万元"的新闻在社交平台引发热议。据悉，该转运过程两名 医护人员随车护送，并携带使用ECMO（体外膜肺氧合）等相关抢救设备和药品。 在此背景下，体外膜肺氧合（ECMO人工肺）再次被推上舆论的风口浪尖，网友对这项治疗的高昂费用 充满不解与疑惑。对此，一位不愿具名的重症科医生接受《华夏时报》记者采访时表示，"ECMO治疗 费用之高昂，并非单一因素所致。其中包括设备采购成本高，配套耗材成本昂贵，运营维护成本高，研 发和生产成本高，市场供需关系影响。此外，ECMO的花费与国产商业化难确实存在一定关联，使用价 格高昂是制约ECMO市场渗透率提升的原因之一。因此设备国产化对降低使用费用和提升患者接受度息 息相关，推动ECMO国产化能够提升市场竞争力倒逼产品价格下降。" 两周花费20万元 ECMO是一种人工心肺机。作为心肺系统重症治疗的一种设备，适用于重症心肺功能衰竭患者，其通过 为患者提供持续的体外氧合与循环支持，减轻患者心肺负担以维持患者生命。 自1972年以来，ECMO铸就了许多重症患者"起死回生"的传奇故事。直至1994年，前中国台大医院 ...

综合媒体报道，今年4月，其身患重症的孩子连夜从江西转运至上海某医院，800公里路程被"民营救护 车"司机收费28000元，没有价格明细和发票，连费用都是转入个人账户。 6月16日下午，"潮新闻"致电江西涉事医院，院方工作人员表示正在核实调查，有结果后会向上级部门 汇报。 据家属透露，该公立三甲医院曾向其解释称，医院的救护车不能出省，无法转运他孩子这样带着呼吸 机、ECMO等器械的病人，再加上是连夜转运，所以医生考虑到各方面原因后，帮其联系了民营救护 车。 多名医疗界人士关注到这一事件。有医生告诉"医学界"，路程长且患儿在转运途中带着呼吸机、ECMO 等设备，或是转运费用较高的主要原因之一，"这位患儿的转运挑战很大，任何一点疏忽都可能导致转 运失败。" 800公里救护车转运并不多见 据"潮新闻"消息，近日，一患儿家属向江西省卫健部门投诉，对江西省某三甲公立医院医生联系的救护 车转运费用提出质疑。 家属向"潮新闻"介绍，今年4月8日晚，因病情恶化，这家江西公立三甲医院主治医生建议其孩子转院治 疗。家属主动提出前往上海，请主治医生帮忙联系救护车转运。 家属表示，8日晚上10点许，一辆救护车停靠在医院门口，车内有两名 ...

Core Viewpoint - Guangdong is transitioning from a "manufacturing province" to an "innovation powerhouse," driven by new production forces and capital market dynamics [1] Group 1: Industry Development - Guangdong's industrial development has evolved from processing trade to a manufacturing leader, and now to a technology innovation frontier [1] - The province faces challenges such as intensified market competition, rising labor costs, and external instability, necessitating structural adjustments and upgrades in its industries [1] Group 2: Role of Capital - Capital markets play a crucial role in Guangdong's industrial upgrade by acting as both "value discoverers" and "resource integrators," facilitating the restructuring and transition of industries [2] - Guangdong has over 12,000 private equity and venture capital funds, with a total scale of 2.47 trillion yuan, supporting technological entrepreneurship and industrial upgrades [2] Group 3: Case Studies - Companies like Midea have engaged in capital operations, acquiring firms such as KUKA to enter the robotics market, demonstrating the active role of capital in industry transformation [3] - The integration of resources by companies like Songfa and Foshan Lighting showcases how capital can help traditional industries innovate and expand into new sectors [3] Group 4: Economic Stability and Growth - The synergy between traditional and emerging industries, supported by capital, contributes to economic stability and creates sustainable growth points for the future [3]